Exchange: NASDAQ·Updated 04:10 PM EDT
News
all
press releases
Cryoport (CYRX) Q2 2026 Earnings Call Transcript
@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo...
Nasdaq News: Markets
More News
CryoPort (CYRX) Upgraded to Buy: Here's Why
CryoPort (CYRX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Zacks
CryoPort, Inc. (CYRX) Reports Q2 Loss, Beats Revenue Estimates
CryoPort (CYRX) delivered earnings and revenue surprises of 0.00% and +1.85%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Cryoport Reports Second Quarter 2026 Financial Results
Cryoport Reports Second Quarter 2026 Financial Results Cryoport Reports Second Quarter 2026 Financial Results PR Newswire NASHVILLE, Tenn., Aug. 6, 2026 Second quarter revenue grew 8% year-over-year to $49.0 millionLife Sciences Services revenue increased 15% year-over-yearBioStorage/BioServices...
PR Newswire
Caris Life Sciences,?Inc. (CAI) Reports Break-Even Earnings for Q2
Caris Life Sciences,?Inc. (CAI) delivered earnings and revenue surprises of +100.00% and +14.07%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Cryoport to Report Second Quarter 2026 Financial Results on August 6, 2026
Cryoport to Report Second Quarter 2026 Financial Results on August 6, 2026 Cryoport to Report Second Quarter 2026 Financial Results on August 6, 2026 PR Newswire NASHVILLE, Tenn., July 23, 2026 NASHVILLE, Tenn., July 23, 2026 /PRNewswire/ -- Cryoport, Inc.(Nasdaq: CYRX) ("Cryoport" or the...
PR Newswire
Cryoport's IntegriCell Cryopreservation Services Selected by Verismo Therapeutics to Support Clinical KIR-CAR T Cell Therapy Programs
Cryoport's IntegriCell Cryopreservation Services Selected by Verismo Therapeutics to Support Clinical KIR-CAR T Cell Therapy Programs Cryoport's IntegriCell Cryopreservation Services Selected by Verismo Therapeutics to Support Clinical KIR-CAR T Cell Therapy Programs PR Newswire NASHVILLE, Tenn...
PR Newswire
CryoPort (NASDAQ:CYRX) Hits New 12-Month High on Analyst Upgrade
CryoPort (NASDAQ:CYRX) Sets New 1-Year High on Analyst Upgrade...
MarketBeat
CryoPort (NASDAQ:CYRX) Shares Gap Up on Analyst Upgrade
CryoPort (NASDAQ:CYRX) Shares Gap Up Following Analyst Upgrade...
MarketBeat
CryoPort (NASDAQ:CYRX) Price Target Raised to $17.00
BTIG Research increased their price target on shares of CryoPort from $15.00 to $17.00 and gave the stock a 'buy' rating in a research note on Tuesday...
MarketBeat

Advertisement|Remove ads.